Cardiovascular Disease Program, Monash Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, VIC 3800, Australia
Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester M13 9PL, UK
Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, VIC 3010, Australia
Authors to whom correspondence should be addressed.
Received: 08 Aug 2023
Accepted: 12 Oct 2023
Published: 17 Oct 2023